Viral Vector-Based Gene Therapy Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Viral Vector-Based Gene Therapy Market Report 2026

Name: Viral Vector-Based Gene Therapy Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Vector Type (Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors), By Delivery Method (Intravenous Injection, Intrathecal Injection, Intramuscular Injection, Subcutaneous Injection, Topical), By Application (Oncology, Genetic Disorders, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Other Applications), By End-User (Hospitals, Clinical Research Organizations (CROs), Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Viral Vector-Based Gene Therapy Market Overview

• Viral Vector-Based Gene Therapy market size has reached to $6.77 billion in 2025

• Expected to grow to $14.81 billion in 2030 at a compound annual growth rate (CAGR) of 16.9%

• Growth Driver: Increasing Prevalence Of Genetic Diseases Fueling The Growth Of The Market Due To Rising Diagnosis And Awareness

• Market Trend: Integrated Systems Boost Efficiency And Reduce Costs

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Viral Vector-Based Gene Therapy Market?

Viral vector-based gene therapy is a medical approach that uses engineered viruses to deliver therapeutic genes into a patient’s cells to treat or prevent diseases. The viral vectors are modified to be safe and replication-deficient while efficiently transferring genetic material to target cells. This therapy enables correction of genetic defects, modulation of gene expression, or stimulation of immune responses to achieve long-lasting therapeutic effects.

The main vector types of viral vector-based gene therapy are adenoviral vectors, adeno-associated viral vectors, lentiviral vectors, retroviral vectors, and others. Adenoviral vectors are engineered viruses derived from adenoviruses that are modified to safely deliver therapeutic genes into target cells without replicating and are commonly used in gene therapy and vaccine applications. It is delivered through various routes, including intravenous injection, intrathecal injection, intramuscular injection, subcutaneous injection, and topical application. It finds applications in oncology, genetic disorders, cardiovascular diseases, infectious diseases, neurological disorders, and others, serving end users such as hospitals, clinical research organizations (CROs), academic and research institutes, pharmaceutical and biotechnology companies, and others.

Viral Vector-Based Gene Therapy Market Global Report 2026 Market Report bar graph

What Is The Viral Vector-Based Gene Therapy Market Size and Share 2026?

The viral vector-based gene therapy market size has grown rapidly in recent years. It will grow from $6.77 billion in 2025 to $7.93 billion in 2026 at a compound annual growth rate (CAGR) of 17.2%. The growth in the historic period can be attributed to advancements in molecular biology research, increasing understanding of genetic disorders, early clinical successes of viral vector therapies, expansion of orphan drug programs, availability of viral vector platforms.

What Is The Viral Vector-Based Gene Therapy Market Growth Forecast?

The viral vector-based gene therapy market size is expected to see rapid growth in the next few years. It will grow to $14.81 billion in 2030 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be attributed to increasing approvals of gene therapy products, rising investment in rare disease treatments, expansion of precision medicine initiatives, growing adoption of personalized healthcare, continuous improvements in vector engineering technologies. Major trends in the forecast period include rising adoption of targeted gene therapies, growing development of personalized treatment approaches, expansion of clinical trials for rare diseases, increasing focus on long-term therapeutic efficacy, enhanced emphasis on vector safety and performance.

Book your 30 minutes free consultation with our research experts

Global Viral Vector-Based Gene Therapy Market Segmentation

1) By Vector Type: Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors

2) By Delivery Method: Intravenous Injection, Intrathecal Injection, Intramuscular Injection, Subcutaneous Injection, Topical

3) By Application: Oncology, Genetic Disorders, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Other Applications

4) By End-User: Hospitals, Clinical Research Organizations (CROs), Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Adenoviral Vectors: Human Adenovirus Serotype Five, Human Adenovirus Serotype Two, Canine Adenovirus

2) By Adeno-Associated Viral Vectors: Adeno-Associated Virus Serotype One, Adeno-Associated Virus Serotype Two, Adeno-Associated Virus Serotype Five, Adeno-Associated Virus Serotype Eight, Other Adeno-Associated Viruses

3) By Lentiviral Vectors: Human Immunodeficiency Virus One, Human Immunodeficiency Virus Two

4) By Retroviral Vectors: Gammaretrovirus, Alpharetrovirus, Spumaretrovirus, Other Retroviruses

What Is The Driver Of The Viral Vector-Based Gene Therapy Market?

The increasing prevalence of genetic diseases is expected to propel the growth of the viral vector-based gene therapy market going forward. Genetic diseases are disorders caused by changes or mutations in DNA, which can be inherited or occur spontaneously, affecting health, development, or body functions. The rising prevalence of genetic diseases is due to increased awareness and advancements in diagnostic technologies, as these enable earlier and more accurate detection of previously undiagnosed conditions. Viral vector-based gene therapy enhances genetic disease management by providing targeted delivery of therapeutic genes, making it ideal for treating inherited disorders. It reduces disease progression by enabling precise and long-lasting correction of genetic defects, improving patient outcomes and quality of life. For instance, in April 2025, according to the International Diabetes Federation (IDF), a Belgium-based non-profit organization, approximately 589 million people were living with diabetes in 2024, and this number is projected to rise to 853 million by 2050. Therefore, the increasing prevalence of genetic diseases is driving the growth of the viral vector-based gene therapy market.

Key Players In The Global Viral Vector-Based Gene Therapy Market

Major companies operating in the viral vector-based gene therapy market are F. Hoffmann-La Roche AG, Novartis AG, BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., Ultragenyx Inc., Rocket Pharmaceuticals Inc., PTC Therapeutics Inc., 4D Molecular Therapeutics Inc., Editas Medicine Inc., Regenxbio Inc., Oxford Biomedica plc, MeiraGTx Holdings plc, Voyager Therapeutics Inc., Solid Biosciences Inc., Sangamo Therapeutics Inc., Adverum Biotechnologies Inc., Passage Bio Inc., Dyno Therapeutics Inc., uniQure N.V., Bluebird Bio Inc.

Global Viral Vector-Based Gene Therapy Market Trends and Insights

Major companies operating in the viral vector-based gene therapy market are focusing on developing advanced platforms, such as integrated manufacturing platforms, to boost efficiency, enhance reliability, and reduce the cost and time of therapy production. Integrated manufacturing platforms refer to comprehensive systems that streamline the entire process of producing gene therapies, from vector design to final product, using standardized, high-yield processes. For instance, in October 2024, Forge Biologics Holdings LLC, a US-based biotechnology company, launched the FUEL AAV Manufacturing Platform. It is a proprietary, suspension-based manufacturing system designed to provide high productivity and scalability. It includes a fully integrated plasmid system and optimized processes, enabling robust and consistent production of adeno-associated viral (AAV) vectors for gene therapies, thereby accelerating developer timelines from research to clinical trials.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Viral Vector-Based Gene Therapy Market?

In July 2023, Sartorius AG, a Germany-based company that provides laboratory and biopharmaceutical equipment and services, acquired Polyplus SAS for an undisclosed amount. Through this acquisition, Sartorius aims to strengthen its capabilities in supplying critical transfection reagents and related technologies that enable the efficient production of viral vectors for gene and gene-modified cell therapies. Polyplus SAS is a France-based company that provides upstream technologies, products, and services for the manufacturing of viral vectors used in gene therapies.

Regional Outlook

North America was the largest region in the viral vector-based gene therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Viral Vector-Based Gene Therapy Market?

The viral vector-based gene therapy market includes revenues earned by entities through process development, vector design, cell line development, assay development, process optimization, manufacturing, upstream production, and downstream purification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Viral Vector-Based Gene Therapy Market Report 2026?

The viral vector-based gene therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the viral vector-based gene therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Viral Vector-Based Gene Therapy Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$7.93 billion
Revenue Forecast In 2035	$14.81 billion
Growth Rate	CAGR of 17.2% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Vector Type, Delivery Method, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F. Hoffmann-La Roche AG, Novartis AG, BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., Ultragenyx Inc., Rocket Pharmaceuticals Inc., PTC Therapeutics Inc., 4D Molecular Therapeutics Inc., Editas Medicine Inc., Regenxbio Inc., Oxford Biomedica plc, MeiraGTx Holdings plc, Voyager Therapeutics Inc., Solid Biosciences Inc., Sangamo Therapeutics Inc., Adverum Biotechnologies Inc., Passage Bio Inc., Dyno Therapeutics Inc., uniQure N.V., Bluebird Bio Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Viral Vector-Based Gene Therapy Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Viral Vector-Based Gene Therapy Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Viral Vector-Based Gene Therapy Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Viral Vector-Based Gene Therapy Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Adoption Of Targeted Gene Therapies

4.2.2 Growing Development Of Personalized Treatment Approaches

4.2.3 Expansion Of Clinical Trials For Rare Diseases

4.2.4 Increasing Focus On Long-Term Therapeutic Efficacy

4.2.5 Enhanced Emphasis On Vector Safety And Performance

5. Viral Vector-Based Gene Therapy Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinical Research Organizations

5.3 Academic And Research Institutes

5.4 Pharmaceutical And Biotechnology Companies

5.5 Gene Therapy Clinics

6. Viral Vector-Based Gene Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Viral Vector-Based Gene Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Viral Vector-Based Gene Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Viral Vector-Based Gene Therapy Market Size, Comparisons And Growth Rate Analysis

7.3. Global Viral Vector-Based Gene Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Viral Vector-Based Gene Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Viral Vector-Based Gene Therapy Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Viral Vector-Based Gene Therapy Market Segmentation

9.1. Global Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors

9.2. Global Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intravenous Injection, Intrathecal Injection, Intramuscular Injection, Subcutaneous Injection, Topical

9.3. Global Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology, Genetic Disorders, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Other Applications

9.4. Global Viral Vector-Based Gene Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinical Research Organizations (CROs), Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

9.5. Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Adenoviral Vectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Human Adenovirus Serotype Five, Human Adenovirus Serotype Two, Canine Adenovirus

9.6. Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Adeno-Associated Viral Vectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adeno-Associated Virus Serotype One, Adeno-Associated Virus Serotype Two, Adeno-Associated Virus Serotype Five, Adeno-Associated Virus Serotype Eight, Other Adeno-Associated Viruses

9.7. Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Lentiviral Vectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Human Immunodeficiency Virus One, Human Immunodeficiency Virus Two

9.8. Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Retroviral Vectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Gammaretrovirus, Alpharetrovirus, Spumaretrovirus, Other Retroviruses

10. Viral Vector-Based Gene Therapy Market Regional And Country Analysis

10.1. Global Viral Vector-Based Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Viral Vector-Based Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Viral Vector-Based Gene Therapy Market

11.1. Asia-Pacific Viral Vector-Based Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Viral Vector-Based Gene Therapy Market

12.1. China Viral Vector-Based Gene Therapy Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Viral Vector-Based Gene Therapy Market

13.1. India Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Viral Vector-Based Gene Therapy Market

14.1. Japan Viral Vector-Based Gene Therapy Market Overview

14.2. Japan Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Viral Vector-Based Gene Therapy Market

15.1. Australia Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Viral Vector-Based Gene Therapy Market

16.1. Indonesia Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Viral Vector-Based Gene Therapy Market

17.1. South Korea Viral Vector-Based Gene Therapy Market Overview

17.2. South Korea Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Viral Vector-Based Gene Therapy Market

18.1. Taiwan Viral Vector-Based Gene Therapy Market Overview

18.2. Taiwan Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Viral Vector-Based Gene Therapy Market

19.1. South East Asia Viral Vector-Based Gene Therapy Market Overview

19.2. South East Asia Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Viral Vector-Based Gene Therapy Market

20.1. Western Europe Viral Vector-Based Gene Therapy Market Overview

20.2. Western Europe Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Viral Vector-Based Gene Therapy Market

21.1. UK Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Viral Vector-Based Gene Therapy Market

22.1. Germany Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Viral Vector-Based Gene Therapy Market

23.1. France Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Viral Vector-Based Gene Therapy Market

24.1. Italy Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Viral Vector-Based Gene Therapy Market

25.1. Spain Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Viral Vector-Based Gene Therapy Market

26.1. Eastern Europe Viral Vector-Based Gene Therapy Market Overview

26.2. Eastern Europe Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Viral Vector-Based Gene Therapy Market

27.1. Russia Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Viral Vector-Based Gene Therapy Market

28.1. North America Viral Vector-Based Gene Therapy Market Overview

28.2. North America Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Viral Vector-Based Gene Therapy Market

29.1. USA Viral Vector-Based Gene Therapy Market Overview

29.2. USA Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Viral Vector-Based Gene Therapy Market

30.1. Canada Viral Vector-Based Gene Therapy Market Overview

30.2. Canada Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Viral Vector-Based Gene Therapy Market

31.1. South America Viral Vector-Based Gene Therapy Market Overview

31.2. South America Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Viral Vector-Based Gene Therapy Market

32.1. Brazil Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Viral Vector-Based Gene Therapy Market

33.1. Middle East Viral Vector-Based Gene Therapy Market Overview

33.2. Middle East Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Viral Vector-Based Gene Therapy Market

34.1. Africa Viral Vector-Based Gene Therapy Market Overview

34.2. Africa Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Segmentation By Delivery Method, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Viral Vector-Based Gene Therapy Market Regulatory and Investment Landscape

36. Viral Vector-Based Gene Therapy Market Competitive Landscape And Company Profiles

36.1. Viral Vector-Based Gene Therapy Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Viral Vector-Based Gene Therapy Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Viral Vector-Based Gene Therapy Market Company Profiles

36.3.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. BioMarin Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sarepta Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Ultragenyx Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Viral Vector-Based Gene Therapy Market Other Major And Innovative Companies

Rocket Pharmaceuticals Inc., PTC Therapeutics Inc., 4D Molecular Therapeutics Inc., Editas Medicine Inc., Regenxbio Inc., Oxford Biomedica plc, MeiraGTx Holdings plc, Voyager Therapeutics Inc., Solid Biosciences Inc., Sangamo Therapeutics Inc., Adverum Biotechnologies Inc., Passage Bio Inc., Dyno Therapeutics Inc., uniQure N.V., Bluebird Bio Inc.

38. Global Viral Vector-Based Gene Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Viral Vector-Based Gene Therapy Market

40. Viral Vector-Based Gene Therapy Market High Potential Countries, Segments and Strategies

40.1 Viral Vector-Based Gene Therapy Market In 2030 - Countries Offering Most New Opportunities

40.2 Viral Vector-Based Gene Therapy Market In 2030 - Segments Offering Most New Opportunities

40.3 Viral Vector-Based Gene Therapy Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Viral Vector-Based Gene Therapy Market, Overview Of Key Products - Product Examples

Table 2: Global Viral Vector-Based Gene Therapy Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Viral Vector-Based Gene Therapy Market, Supply Chain Analysis

Table 4: Global Viral Vector-Based Gene Therapy Market, Major Raw Material Providers

Table 5: Global Viral Vector-Based Gene Therapy Market, Major Resource Providers

Table 6: Global Viral Vector-Based Gene Therapy Market, Major Manufacturers (Suppliers)

Table 7: Global Viral Vector-Based Gene Therapy Market, Major Distributors And Channel Partners

Table 8: Global Viral Vector-Based Gene Therapy Market, Key Technologies & Future Trends

Table 9: Global Viral Vector-Based Gene Therapy Market, Major Trends

Table 10: Global Viral Vector-Based Gene Therapy Market, Major End Users

Table 11: Global Viral Vector-Based Gene Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Viral Vector-Based Gene Therapy Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Viral Vector-Based Gene Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Viral Vector-Based Gene Therapy Market - TAM, US$ Billion, 2025

Table 15: Global Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Viral Vector-Based Gene Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Adenoviral Vectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Adeno-Associated Viral Vectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Lentiviral Vectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Retroviral Vectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Viral Vector-Based Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Viral Vector-Based Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Viral Vector-Based Gene Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Viral Vector-Based Gene Therapy Market - Company Scoring Matrix

Table 99: F. Hoffmann-La Roche AG Financial Performance

Table 100: Novartis AG Financial Performance

Table 101: BioMarin Pharmaceutical Inc. Financial Performance

Table 102: Sarepta Therapeutics Inc. Financial Performance

Table 103: Ultragenyx Inc. Financial Performance

Table 104: Global Viral Vector-Based Gene Therapy Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Viral Vector-Based Gene Therapy Market, Competitive Dashboard

Table 106: Global Viral Vector-Based Gene Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Viral Vector-Based Gene Therapy Market Size Gain ($ Billion), Segmentation By Vector Type, 2025 – 2030

Table 108: Global, Viral Vector-Based Gene Therapy Market Size Gain ($ Billion), Segmentation By Delivery Method, 2025 – 2030

Table 109: Global, Viral Vector-Based Gene Therapy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Viral Vector-Based Gene Therapy Market, Overview Of Key Products - Product Examples

Figure 2: Global Viral Vector-Based Gene Therapy Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Viral Vector-Based Gene Therapy Market, Supply Chain Analysis

Figure 4: Global Viral Vector-Based Gene Therapy Market, Major Raw Material Providers

Figure 5: Global Viral Vector-Based Gene Therapy Market, Major Resource Providers

Figure 6: Global Viral Vector-Based Gene Therapy Market, Major Manufacturers (Suppliers)

Figure 7: Global Viral Vector-Based Gene Therapy Market, Major Distributors And Channel Partners

Figure 8: Global Viral Vector-Based Gene Therapy Market, Key Technologies & Future Trends

Figure 9: Global Viral Vector-Based Gene Therapy Market, Major Trends

Figure 10: Global Viral Vector-Based Gene Therapy Market, Major End Users

Figure 11: Global Viral Vector-Based Gene Therapy Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Viral Vector-Based Gene Therapy Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Viral Vector-Based Gene Therapy Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Viral Vector-Based Gene Therapy Market - TAM, US$ Billion, 2025

Figure 15: Global Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Viral Vector-Based Gene Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Adenoviral Vectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Adeno-Associated Viral Vectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Lentiviral Vectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Retroviral Vectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Viral Vector-Based Gene Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Viral Vector-Based Gene Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Viral Vector-Based Gene Therapy Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Viral Vector-Based Gene Therapy Market - Company Scoring Matrix

Figure 99: F. Hoffmann-La Roche AG Financial Performance

Figure 100: Novartis AG Financial Performance

Figure 101: BioMarin Pharmaceutical Inc. Financial Performance

Figure 102: Sarepta Therapeutics Inc. Financial Performance

Figure 103: Ultragenyx Inc. Financial Performance

Figure 104: Global Viral Vector-Based Gene Therapy Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Viral Vector-Based Gene Therapy Market, Competitive Dashboard

Figure 106: Global Viral Vector-Based Gene Therapy Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Viral Vector-Based Gene Therapy Market Size Gain ($ Billion), Segmentation By Vector Type, 2025 – 2030

Figure 108: Global, Viral Vector-Based Gene Therapy Market Size Gain ($ Billion), Segmentation By Delivery Method, 2025 – 2030

Figure 109: Global, Viral Vector-Based Gene Therapy Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Major Drivers Propelling the Growth oh theMedical Imaging And Radiology Software Market Forward: Growing Prevalence Of Chronic Diseases Fuels Growth In The Medical Imaging And Radiology Software Market

Strategic Growth Drivers Shaping the Medical Polycarbonate Market Outlook 2025- 2034:Impact Of Increased Prevalence Of Chronic Diseases On The Medical Polycarbonate Market

Emerging Growth Drivers in the Medical X-Ray Equipment And Imaging Software Market Landscape: Degenerative Joint Diseases Fueling Growth Of The Medical X-Ray Equipment And Imaging Software Market

Mesenchymal Stem Cells Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Gene Therapy Market Report 2026 - Global Outlook – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis,...

Antiviral Combination Therapy Market Report 2026 - Global Outlook – By Type (Branded, Generic), By Drug Combination (Nucleotide Reverse Transcriptase Inhibitors/Non-Nucleotide Reverse Transcriptase Inhibitors, Integrase ...

Oral Expectorant Market Report 2026 - Global Outlook – By Drug Type (Secretion Enhancer, Mucolytics), By Dosage Form (Oral Solids, Oral Liquids, Inhalants), By Medication (Prescription drugs, Over The Counter Drugs), By ...

Oncolytic Virus Therapy Market Report 2026 - Global Outlook – By Therapy Type (Herpes Simplex Virus (HSV)-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, Newcastle Disease V...

Viral Vector Manufacturing Market Report 2026 - Global Outlook – By Type (Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types), By Disease (Cancer, Genetic Disorders, I...

Viral And Non-Viral Vector Manufacturing Market Report 2026 - Global Outlook – By Vector Type (Viral Vector, Non-Viral Vector), By Disease (Cancer, Genetic Disease, Infectious Disease, Cardiovascular Disease, Other Disea...

COVID-19 Current Therapy Market Report 2026 - Global Outlook – By Drug Type (Antiviral, Monoclonal Antibodies, Corticosteroid, Supplements, Antimalarial, Interferons And Interleukin Inhibitors, Other Anti-Infective Drugs...

Frequently Asked Questions

What is the projected market size of the Viral Vector-Based Gene Therapy Market Report 2026 market by 2030?

The Viral Vector-Based Gene Therapy Market Report 2026 market was valued at $6.77 billion in 2025, increased to $7.93 billion in 2026, and is projected to reach $14.81 billion by 2030. request a sample here

What is the expected CAGR for the Viral Vector-Based Gene Therapy Market Report 2026 market during the forecast period 2025 - 2030?

The expected CAGR for the Viral Vector-Based Gene Therapy Market Report 2026 market during the forecast period 2025–2030 is 16.9%. request a sample here

What are the key factors driving the Viral Vector-Based Gene Therapy Market Report 2026 market?

Major growth driver of the market includes: Increasing Prevalence Of Genetic Diseases Fueling The Growth Of The Market Due To Rising Diagnosis And Awareness in the Viral Vector-Based Gene Therapy Market Report 2026 market. For further insights on this market, request a sample here

Which end-use segment are covered in the Viral Vector-Based Gene Therapy Market Report 2026 market report?

The viral vector-based gene therapy market covered in this report is segmented –
1) By Vector Type: Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors
2) By Delivery Method: Intravenous Injection, Intrathecal Injection, Intramuscular Injection, Subcutaneous Injection, Topical
3) By Application: Oncology, Genetic Disorders, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Other Applications
4) By End-User: Hospitals, Clinical Research Organizations (CROs), Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users Subsegments:
1) By Adenoviral Vectors: Human Adenovirus Serotype Five, Human Adenovirus Serotype Two, Canine Adenovirus
2) By Adeno-Associated Viral Vectors: Adeno-Associated Virus Serotype One, Adeno-Associated Virus Serotype Two, Adeno-Associated Virus Serotype Five, Adeno-Associated Virus Serotype Eight, Other Adeno-Associated Viruses
3) By Lentiviral Vectors: Human Immunodeficiency Virus One, Human Immunodeficiency Virus Two
4) By Retroviral Vectors: Gammaretrovirus, Alpharetrovirus, Spumaretrovirus, Other Retroviruses request a sample here

What is the anticipated growth trend for the Viral Vector-Based Gene Therapy Market Report 2026 market?

Major trend in this market includes: Integrated Systems Boost Efficiency And Reduce Costs For further insights on this market, request a sample here.

Who are the key players in the Viral Vector-Based Gene Therapy Market Report 2026 market?

Major companies operating in the Viral Vector-Based Gene Therapy Market Report 2026 market are Major companies operating in the viral vector-based gene therapy market are F. Hoffmann-La Roche AG, Novartis AG, BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., Ultragenyx Inc., Rocket Pharmaceuticals Inc., PTC Therapeutics Inc., 4D Molecular Therapeutics Inc., Editas Medicine Inc., Regenxbio Inc., Oxford Biomedica plc, MeiraGTx Holdings plc, Voyager Therapeutics Inc., Solid Biosciences Inc., Sangamo Therapeutics Inc., Adverum Biotechnologies Inc., Passage Bio Inc., Dyno Therapeutics Inc., uniQure N.V., Bluebird Bio Inc. request a sample here.

Which region has the most growth potential in the Viral Vector-Based Gene Therapy Market Report 2026 market?

North America was the largest region in the viral vector-based gene therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector-based gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.